Neurology & Neurotherapeutics - NE Outside Agreements

Research Output

Filter
Review article
2019

Clinical trials in multiple sclerosis: potential future trial designs

Manouchehri, N., Zhang, Y., Salter, A., Hussain, R. Z., Hartung, H. P., Hemmer, B., Linker, R., Segal, B. M., Cutter, G. & Stüve, O., May 1 2019, In : Therapeutic Advances in Neurological Disorders. 12

Research output: Contribution to journalReview article

Open Access
2 Scopus citations

Evolution of clinical trials in multiple sclerosis

Zhang, Y., Salter, A., Wallström, E., Cutter, G. & Stüve, O., Feb 1 2019, In : Therapeutic Advances in Neurological Disorders. 12

Research output: Contribution to journalReview article

2 Scopus citations

Immunological aspects of approved MS therapeutics

Rommer, P. S., Milo, R., Han, M. H., Satyanarayan, S., Sellner, J., Hauer, L., Illes, Z., Warnke, C., Laurent, S., Weber, M. S., Zhang, Y. & Stuve, O., Jan 1 2019, In : Frontiers in immunology. 10, JULY, 1564.

Research output: Contribution to journalReview article

Open Access
10 Scopus citations

Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders

International Conference on Spinal Cord Involvement and Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders, Feb 1 2019, In : The Lancet Neurology. 18, 2, p. 185-197 13 p.

Research output: Contribution to journalReview article

17 Scopus citations
2018

B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets

Forsthuber, T. G., Cimbora, D. M., Ratchford, J. N., Katz, E. & Stüve, O., Jan 1 2018, In : Therapeutic Advances in Neurological Disorders. 11

Research output: Contribution to journalReview article

14 Scopus citations

Emerging drugs for primary progressive multiple sclerosis

Narayan, R. N., Forsthuber, T. & Stüve, O., Apr 3 2018, In : Expert Opinion on Emerging Drugs. 23, 2, p. 97-110 14 p.

Research output: Contribution to journalReview article

4 Scopus citations
2017

B-cell-Targeted therapies in relapsing forms of MS

Dubey, D., Forsthuber, T., Flanagan, E. P., Pittock, S. J. & Stüve, O., Oct 23 2017, In : Neurology: Neuroimmunology and NeuroInflammation. 4, 6, e405.

Research output: Contribution to journalReview article

5 Scopus citations

Phosphatidylserine-targeted nanotheranostics for brain tumor imaging and therapeutic potential

Wang, L., Habib, A. A., Mintz, A., Li, K. C. & Zhao, D., 2017, In : Molecular Imaging. 16

Research output: Contribution to journalReview article

2 Scopus citations

The role of EGFR-met interactions in the pathogenesis of glioblastoma and resistance to treatment

Guo, G., Narayan, R. N., Horton, L., Patel, T. R. & Habib, A. A., Mar 1 2017, In : Current Cancer Drug Targets. 17, 3, p. 297-302 6 p.

Research output: Contribution to journalReview article

8 Scopus citations
2016

B cell-directed therapies in multiple sclerosis

Gasperi, C., Stüve, O. & Hemmer, B., 2016, In : Neurodegenerative disease management. 6, 1, p. 37-47 11 p.

Research output: Contribution to journalReview article

19 Scopus citations

Diagnostic and therapeutic strategies for management of autoimmune encephalopathies

Dubey, D., Blackburn, K., Greenberg, B., Stuve, O. & Vernino, S., Aug 2 2016, In : Expert Review of Neurotherapeutics. 16, 8, p. 937-949 13 p.

Research output: Contribution to journalReview article

14 Scopus citations
2015

A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis

Marrie, R. A., Reider, N., Cohen, J., Stuve, O., Sorensen, P. S., Cutter, G., Reingold, S. C. & Trojano, M., Mar 16 2015, In : Multiple Sclerosis Journal. 21, 3, p. 282-293 12 p.

Research output: Contribution to journalReview article

56 Scopus citations

A systematic review of the incidence and prevalence of cancer in multiple sclerosis

Marrie, R. A., Reider, N., Cohen, J., Stuve, O., Trojano, M., Sorensen, P. S., Reingold, S. C. & Cutter, G., Mar 16 2015, In : Multiple Sclerosis Journal. 21, 3, p. 294-304 11 p.

Research output: Contribution to journalReview article

39 Scopus citations

A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis

Marrie, R. A., Reider, N., Cohen, J., Stuve, O., Trojano, M., Cutter, G., Reingold, S. & Sorensen, P. S., Mar 16 2015, In : Multiple Sclerosis Journal. 21, 3, p. 318-331 14 p.

Research output: Contribution to journalReview article

63 Scopus citations

A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview

Marrie, R. A., Cohen, J., Stuve, O., Trojano, M., Sørensen, P. S., Reingold, S., Cutter, G. & Reider, N., Mar 16 2015, In : Multiple Sclerosis Journal. 21, 3, p. 263-281 19 p.

Research output: Contribution to journalReview article

106 Scopus citations

A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis

Marrie, R. A., Reider, N., Cohen, J., Trojano, M., Sorensen, P. S., Cutter, G., Reingold, S. & Stuve, O., Mar 16 2015, In : Multiple Sclerosis Journal. 21, 3, p. 342-349 8 p.

Research output: Contribution to journalReview article

45 Scopus citations

B lymphocytes in neuromyelitis optica

Bennett, J. L., O'Connor, K. C., Bar-Or, A., Zamvil, S. S., Hemmer, B., Tedder, T. F., Von Budingen, H. C., Stuve, O., Yeaman, M. R., Smith, T. J. & Stadelmann, C., Jun 2015, In : Neurology: Neuroimmunology and NeuroInflammation. 2, 3, p. e104

Research output: Contribution to journalReview article

53 Scopus citations

Demographic and clinical features of neuromyelitis optica: A review

Pandit, L., Asgari, N., Apiwattanakul, M., Palace, J., Paul, F., Leite, M. I., Kleiter, I., Chitnis, T., Iorio, R., Würfel, J., Paul, F., Van Pelt, D., Rogier, H., Tedder, T., Saiz, A., Villoslada, P., Levy, M., Pandit, L., Klawiter, E., Weinshenker, B. & 30 others, Wingerchuk, D., Kim, H. J., Tenembaum, S., Palace, J., Leite, M. I., Apiwattanakul, M., Broadley, S., Prayoonwiwat, N., Kleiter, I., Hellwig, K., Han, M., Banwell, B., Van Herle, K., Jacob, A., Hooper, C., Kazutoshi Sato, D., Nakashima, I., Fujihara, K., Bichuetti, D., Aktas, O., De Seze, J., Yeaman, M., Waubant, E., Zamvil, S., Bennett, J., Smith, T., Lana-Peixoto, M., Asgari, N., Greenberg, B. & Stuve, O., Jun 6 2015, In : Multiple Sclerosis Journal. 21, 7, p. 845-853 9 p.

Research output: Contribution to journalReview article

115 Scopus citations

Dimethyl fumarate in relapsing-remitting multiple sclerosis: Rationale, mechanisms of action, pharmacokinetics, efficacy and safety

Dubey, D., Kieseier, B. C., Hartung, H. P., Hemmer, B., Warnke, C., Menge, T., Miller-Little, W. A. & Stuve, O., Apr 1 2015, In : Expert review of neurotherapeutics. 15, 4, p. 339-346 8 p.

Research output: Contribution to journalReview article

40 Scopus citations

The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: A systematic review

Marrie, R. A., Reider, N., Stuve, O., Trojano, M., Sorensen, P. S., Cutter, G. R., Reingold, S. C. & Cohen, J., Mar 16 2015, In : Multiple Sclerosis Journal. 21, 3, p. 332-341 10 p.

Research output: Contribution to journalReview article

22 Scopus citations

The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review

Marrie, R. A., Reingold, S., Cohen, J., Stuve, O., Trojano, M., Sorensen, P. S., Cutter, G. & Reider, N., Mar 16 2015, In : Multiple Sclerosis Journal. 21, 3, p. 305-317 13 p.

Research output: Contribution to journalReview article

175 Scopus citations

Update on biomarkers in neuromyelitis optica

GJCFICC&BR, Jan 1 2015, In : Neurology: Neuroimmunology and NeuroInflammation. 2, 4, e134.

Research output: Contribution to journalReview article

Open Access
56 Scopus citations

Use of advanced magnetic resonance imaging techniques in neuromyelitis optica spectrum disorder

Guthy-Jackson Charitable Foundation (GJCF) Neuromyelitis Optica (NMO) International Clinical Consortium and Biorepository, Jul 1 2015, In : JAMA neurology. 72, 7, p. 815-822 8 p.

Research output: Contribution to journalReview article

32 Scopus citations
2014

Alemtuzumab: The advantages and challenges of a novel therapy in MS

Menge, T., Stüve, O., Kieseier, B. C. & Hartung, H. P., Jul 1 2014, In : Neurology. 83, 1, p. 87-97 11 p.

Research output: Contribution to journalReview article

35 Scopus citations

Body fluid biomarkers in multiple sclerosis: How far we have come and how they could affect the clinic now and in the future

Raphael, I., Webb, J., Stuve, O., Haskins, W. & Forsthuber, T., Jan 1 2014, In : Expert review of clinical immunology. 11, 1, p. 69-91 23 p.

Research output: Contribution to journalReview article

29 Scopus citations

Clinical management of multiple sclerosis and neuromyelitis optica with therapeutic monoclonal antibodies: Approved therapies and emerging candidates

Dubey, D., Kieseier, B. C., Hartung, H. P., Hemmer, B., Miller-Little, W. A. & Stuve, O., Jan 1 2014, In : Expert review of clinical immunology. 11, 1, p. 93-108 16 p.

Research output: Contribution to journalReview article

13 Scopus citations

Defining the clinical course of multiple sclerosis: The 2013 revisions

Lublin, F. D., Reingold, S. C., Cohen, J. A., Cutter, G. R., Sørensen, P. S., Thompson, A. J., Wolinsky, J. S., Balcer, L. J., Banwell, B., Barkhof, F., Bebo, B., Calabresi, P. A., Clanet, M., Comi, G., Fox, R. J., Freedman, M. S., Goodman, A. D., Inglese, M., Kappos, L., Kieseier, B. C. & 12 others, Lincoln, J. A., Lubetzki, C., Miller, A. E., Montalban, X., O'Connor, P. W., Petkau, J., Pozzilli, C., Rudick, R. A., Sormani, M. P., Stüve, O., Waubant, E. & Polman, C. H., Jul 15 2014, In : Neurology. 83, 3, p. 278-286 9 p.

Research output: Contribution to journalReview article

959 Scopus citations

Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence?

Cutter, G. R. & Stüve, O., Sep 2014, In : Multiple Sclerosis. 20, 10, p. 1304-1305 2 p.

Research output: Contribution to journalReview article

37 Scopus citations

Immune surveillance of the central nervous system in multiple sclerosis - Relevance for therapy and experimental models

Hussain, R. Z., Hayardeny, L., Cravens, P. C., Yarovinsky, F., Eagar, T. N., Arellano, B., Deason, K., Castro-Rojas, C. & Stüve, O., Nov 15 2014, In : Journal of Neuroimmunology. 276, 1-2, p. 9-17 9 p.

Research output: Contribution to journalReview article

21 Scopus citations

Immunophenotyping of cerebrospinal fluid cells in multiple sclerosis: In search of biomarkers

Alvermann, S., Hennig, C., Stüve, O., Wiendl, H. & Stangel, M., Jul 2014, In : JAMA Neurology. 71, 7, p. 905-912 8 p.

Research output: Contribution to journalReview article

28 Scopus citations

Isoniazid in autoimmunity: A trigger for multiple sclerosis?

Nourbakhsh, B. & Stüve, O., Sep 2014, In : Therapeutic Advances in Neurological Disorders. 7, 5, p. 253-256 4 p.

Research output: Contribution to journalReview article

3 Scopus citations

Para-dichlorobenzene toxicity - a review of potential neurotoxic manifestations

Dubey, D., Sharma, V. D., Pass, S. E., Sawhney, A. & Stüve, O., May 2014, In : Therapeutic Advances in Neurological Disorders. 7, 3, p. 177-187 11 p.

Research output: Contribution to journalReview article

8 Scopus citations
2013

The utility of cerebrospinal fluid analysis in patients with multiple sclerosis

Stangel, M., Fredrikson, S., Meinl, E., Petzold, A., Stüve, O. & Tumani, H., May 1 2013, In : Nature Reviews Neurology. 9, 5, p. 267-276 10 p.

Research output: Contribution to journalReview article

95 Scopus citations
2012

Current treatment strategies for multiple sclerosis - efficacy versus neurological adverse effects

Weber, M. S., Menge, T., Lehmann-Horn, K., Kronsbein, H. C., Zettl, U., Sellner, J., Hemmer, B. & Stüve, O., Feb 1 2012, In : Current Pharmaceutical Design. 18, 2, p. 209-219 11 p.

Research output: Contribution to journalReview article

39 Scopus citations

Immune-mediated CNS diseases: A review on nosological classification and clinical features

Zettl, U. K., Stüve, O. & Patejdl, R., Jan 1 2012, In : Autoimmunity Reviews. 11, 3, p. 167-173 7 p.

Research output: Contribution to journalReview article

57 Scopus citations

Treatment of neuromyelitis optica: Review and recommendations

Kimbrough, D. J., Fujihara, K., Jacob, A., Lana-Peixoto, M. A., Isabel Leite, M., Levy, M., Marignier, R., Nakashima, I., Palace, J., De Seze, J., Stuve, O., Tenembaum, S. N., Traboulsee, A., Waubant, E., Weinshenker, B. G. & Wingerchuk, D. M., Oct 1 2012, In : Multiple Sclerosis and Related Disorders. 1, 4, p. 180-187 8 p.

Research output: Contribution to journalReview article

133 Scopus citations
2011

A critical appraisal of treatment decisions in multiple sclerosisĝ€"old versus new

Kieseier, B. C. & Stüve, O., May 1 2011, In : Nature Reviews Neurology. 7, 5, p. 255-262 8 p.

Research output: Contribution to journalReview article

57 Scopus citations

Chronic cerebrospinal venous insufficiency and multiple sclerosis

Bagert, B. A., Marder, E. & Stüve, O., Nov 1 2011, In : Archives of neurology. 68, 11, p. 1379-1384 6 p.

Research output: Contribution to journalReview article

15 Scopus citations

Critical appraisal of the role of fingolimod in the treatment of multiple sclerosis

Warnke, C., Stüve, O., Hartung, H. P., Fogdell-Hahn, A. & Kieseier, B. C., Nov 16 2011, In : Neuropsychiatric Disease and Treatment. 7, 1, p. 519-527 9 p.

Research output: Contribution to journalReview article

14 Scopus citations

Multiple sclerosis and chronic cerebrospinal venous insufficiency: A critical review

Awad, A. M., Marder, E., Milo, R. & Stüve, O., Jul 2011, In : Therapeutic Advances in Neurological Disorders. 4, 4, p. 231-235 5 p.

Research output: Contribution to journalReview article

5 Scopus citations

Risks and benefits of multiple sclerosis therapies: Need for continual assessment?

Kieseier, B. C., Wiendl, H., Hartung, H. P., Leussink, V. I. & Stüve, O., Jun 1 2011, In : Current Opinion in Neurology. 24, 3, p. 238-243 6 p.

Research output: Contribution to journalReview article

16 Scopus citations

Symptomatic therapy in multiple sclerosis

Frohman, T. C., Castro, W., Shah, A., Ortstadt, J. L., Ortstadt, J., Davis, S. L., Logan, D., Abraham, T., Abraham, J., Remington, G., Treadaway, K., Greenberg, B., Shah, A., Hart, J., Stuve, O., Lemack, G. E. & Frohman, E., Mar 2011, In : Therapeutic Advances in Neurological Disorders. 4, 2, p. 83-98 16 p.

Research output: Contribution to journalReview article

17 Scopus citations

The increasing incidence and prevalence of female multiple sclerosis-A critical analysis of potential environmental factors

Sellner, J., Kraus, J., Awad, A., Milo, R., Hemmer, B. & Stüve, O., Jun 1 2011, In : Autoimmunity Reviews. 10, 8, p. 495-502 8 p.

Research output: Contribution to journalReview article

122 Scopus citations
2010

Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis

Awad, A., Hemmer, B., Hartung, H. P., Kieseier, B., Bennett, J. L. & Stuve, O., Feb 1 2010, In : Journal of Neuroimmunology. 219, 1-2, p. 1-7 7 p.

Research output: Contribution to journalReview article

65 Scopus citations

Epidermal growth factor receptor in glioma: Signal transduction, neuropathology, imaging, and radioresistance1

Hatanpaa, K. J., Burma, S., Zhao, D. & Habib, A. A., Sep 2010, In : Neoplasia. 12, 9, p. 675-684 10 p.

Research output: Contribution to journalReview article

237 Scopus citations

Identification of targets and new developments in the treatment of multiple sclerosis-focus on cladribine

Warnke, C., Wiendl, H., Hartung, H. P., Stüve, O. & Kieseier, B. C., Dec 1 2010, In : Drug Design, Development and Therapy. 4, p. 117-126 10 p.

Research output: Contribution to journalReview article

10 Scopus citations

Immunomodulation in multiple sclerosis

Leussink, V. I., Stüve, O., Hö;rste, G. M. Z. & Kieseier, B. C., Dec 1 2010, In : Hot Topics in Neurology and Psychiatry. 9, p. 17-21 5 p.

Research output: Contribution to journalReview article

Management of children with holoprosencephaly

Levey, E. B., Stashinko, E., Clegg, N. J. & Delgado, M. R., Feb 15 2010, In : American Journal of Medical Genetics, Part C: Seminars in Medical Genetics. 154, 1, p. 183-190 8 p.

Research output: Contribution to journalReview article

54 Scopus citations

Natalizumab and progressive multifocal leukoencephalopathy: What are the causal factors and can it be avoided?

Warnke, C., Menge, T., Hartung, H. P., Racke, M. K., Cravens, P. D., Bennett, J. L., Frohman, E., Greenberg, B., Zamvil, S. S., Gold, R., Hemmer, B., Kieseier, B. C. & Stuve, O., Aug 1 2010, In : Archives of neurology. 67, 8, p. 923-930 8 p.

Research output: Contribution to journalReview article

94 Scopus citations

Pharmacologic treatment of spasticity in children

Tilton, A., Vargus-Adams, J. & Delgado, M. R., Dec 1 2010, In : Seminars in Pediatric Neurology. 17, 4, p. 261-267 7 p.

Research output: Contribution to journalReview article

16 Scopus citations